Page last updated: 2024-09-05

sch 58261 and theophylline

sch 58261 has been researched along with theophylline in 4 studies

Compound Research Comparison

Studies
(sch 58261)
Trials
(sch 58261)
Recent Studies (post-2010)
(sch 58261)
Studies
(theophylline)
Trials
(theophylline)
Recent Studies (post-2010) (theophylline)
4601420,0761,6121,383

Protein Interaction Comparison

ProteinTaxonomysch 58261 (IC50)theophylline (IC50)
Adenosine receptor A1Bos taurus (cattle)2.43

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C1
Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L1
de Lera Ruiz, M; Lim, YH; Zheng, J1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G1

Reviews

3 review(s) available for sch 58261 and theophylline

ArticleYear
Fluorescent ligands for adenosine receptors.
    Bioorganic & medicinal chemistry letters, 2013, Jan-01, Volume: 23, Issue:1

    Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1

2013
Adenosine A2A receptor as a drug discovery target.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction

2014
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship

2022

Other Studies

1 other study(ies) available for sch 58261 and theophylline

ArticleYear
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles

1997